Federal Judge Halts RFK Jr's Vaccine Advisory Committee Restructuring
A federal judge has issued a significant ruling that blocks the overhaul of vaccine recommendations initiated by Health and Human Services Secretary Robert F Kennedy Jr. The court found that the unprecedented changes to routine US immunization schedules, implemented in January, were "arbitrary and capricious." This decision comes in response to a lawsuit filed by the American Academy of Pediatrics against the US Department of Health and Human Services.
Invalidation of Advisory Committee Appointments
Judge Brian E Murphy determined that Kennedy's actions in June, when he fired all 17 members of the Advisory Committee on Immunization Practices and replaced them with hand-picked advisers, many holding anti-vaccine views, likely violated the Federal Advisory Committee Act. Consequently, the judge stayed the 13 new appointments, effectively invalidating their roles on the committee.
All votes taken by these advisers over the past year have been nullified. This includes decisions such as banning thimerosal from flu vaccines, ending the recommendation for the combination measles, mumps, and rubella and chickenpox vaccine, and discontinuing the universal birth dose recommendation for the hepatitis B vaccine.
Immediate Consequences and Postponed Meeting
As a result of this ruling, the ACIP is unable to meet later this week, and the meeting has been postponed, according to an HHS official. The committee had planned to focus on purported long-term effects after Covid vaccination, based on a leaked memo first reported by the New York Times.
Robert Malone, co-chair of the committee, expressed frustration over the leak, stating on social media that unintended consequences are unfolding. Meanwhile, Elizabeth Jacobs, a member of Defend Public Health and an epidemiologist, criticized the ACIP under Kennedy for pushing unscientific misinformation about vaccines.
Legal and Public Health Implications
Richard Hughes IV, a lawyer representing the AAP, hailed the ruling as a major victory. However, HHS spokesperson Andrew Nixon indicated that the department looks forward to the decision being overturned, comparing it to previous attempts to impede governance.
Dorit Reiss, a vaccine law expert and professor at UC Law San Francisco, noted that the future of the US vaccines landscape hinges on the government's next steps, likely involving an appeal. She added that reversing the January changes could improve access in states that rely on the committee's recommendations for vaccine coverage and pharmacist powers.
This legal battle underscores ongoing tensions in US public health policy, with significant implications for immunization practices and advisory committee governance.
